Stock Information
Zymeworks Inc (ZYME)
Ticker Symbol: ZYME
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,618.07 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.37
Revenue (TTM): $1.09 M
Dividend Yield: N/A
ROE: -37.79%
Latest News
-
Zymeworks: Transitioning Into A Royalty-Driven Biopharma Platform Post Ziihera Approval
Thu, Aug 27, 2026 7:45 AM
-
Citigroup Maintains Buy on Zymeworks, Raises Price Target to $38
Wed, Aug 26, 2026 11:39 AM
-
Abercrombie & Fitch Posts Upbeat Q2 Results, Joins Semtech, Summit Therapeutics And Other Big Stocks Moving Higher On Wednesday
Wed, Aug 26, 2026 10:16 AM
-
MongoDB To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday
Wed, Aug 26, 2026 9:26 AM
-
Citizens Reiterates Market Outperform on Zymeworks, Maintains $32 Price Target
Wed, Aug 26, 2026 8:46 AM
-
HC Wainwright & Co. Maintains Buy on Zymeworks, Raises Price Target to $55
Wed, Aug 26, 2026 6:12 AM
-
Jazz Pharmaceuticals Wins FDA Approval For Two Advanced Gastric Cancer Regimens
Tue, Aug 25, 2026 12:51 PM
Key Financials
Financial data not available
